TÜRKÇE
|
ENGLISH
HAKKIMIZDA
Psychiatry and Clinical Psychopharmacology
Kurullar
SAYILAR
Son Sayı
Arşiv
DERGİ POLİTİKALARI
Gizlilik Politikası
Reklam Politikası
Editoryal Politikalar ve Hakem Sistemi
YAZARLARA BİLGİ
Yazarlar İçin Açıklamalar
Online Gönderim Hakknda
Telif Hakkı Devir Formu
HAKEMLER İÇİN REHBER
ÖDÜLLER VE TEŞVİKLER
İLETİŞİM
ONLINE MAKALE GİRİŞİ
Psychiatry & Clinical Psychopharmacology eski adıyla Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology
SON DUYURULAR
06.03.2017
Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 2017’den itibaren...
Devamı
Tüm Duyurular
CİLT: 26 SAYI: 4
2016 CİLT : 26 - SAYI : 1
2016 CİLT : 26 - SAYI : Ek 1
2016 CİLT : 26 - SAYI : 2
2016 CİLT : 26 - SAYI : 3
2016 CİLT : 26 - SAYI : 4
2015 CİLT : 25 - SAYI : 1
2015 CİLT : 25 - SAYI : 2
2015 CİLT : 25 - SAYI : Ek 1
2015 CİLT : 25 - SAYI : 3
2015 CİLT : 25 - SAYI : 4
2014 CİLT : 24 - SAYI : 1
2014 CİLT : 24 - SAYI : 2
2014 CİLT : 24 - SAYI : 3
2014 CİLT : 24 - SAYI : 4
2014 CİLT : 24 - SAYI : Ek 1
2013 CİLT : 23 - SAYI : 1
2013 CİLT : 23 - SAYI : 2
2013 CİLT : 23 - SAYI : 3
2013 CİLT : 23 - SAYI : 4
2013 CİLT : 23 - SAYI : Ek 1
2012 CİLT : 22 - SAYI : 1
2012 CİLT : 22 - SAYI : 2
2012 CİLT : 22 - SAYI : 3
2012 CİLT : 22 - SAYI : 4
2012 CİLT : 22 - SAYI : Ek 1
2011 CİLT : 21 - SAYI : 1
2011 CİLT : 21 - SAYI : 2
2011 CİLT : 21 - SAYI : 3
2011 CİLT : 21 - SAYI : 4
2011 CİLT : 21 - SAYI : Ek 1
2011 CİLT : 21 - SAYI : Ek 2
2010 CİLT : 20 - SAYI : 1
2010 CİLT : 20 - SAYI : 2
2010 CİLT : 20 - SAYI : 3
2010 CİLT : 20 - SAYI : 4
2010 CİLT : 20 - SAYI : Ek 1
2009 CİLT : 19 - SAYI : 1
2009 CİLT : 19 - SAYI : 2
2009 CİLT : 19 - SAYI : 3
2009 CİLT : 19 - SAYI : 4
2009 CİLT : 19 - SAYI : Ek 1
2009 CİLT : 19 - SAYI : Ek 2
2008 CİLT : 18 - SAYI : 1
2008 CİLT : 18 - SAYI : 2
2008 CİLT : 18 - SAYI : 3
2008 CİLT : 18 - SAYI : 4
2008 CİLT : 18 - SAYI : Ek 1
2008 CİLT : 18 - SAYI : Ek 2
2007 CİLT : 17 - SAYI : 1
2007 CİLT : 17 - SAYI : 2
2007 CİLT : 17 - SAYI : 3
2007 CİLT : 17 - SAYI : 4
2006 CİLT : 16 - SAYI : 1
2006 CİLT : 16 - SAYI : 2
2006 CİLT : 16 - SAYI : 3
2006 CİLT : 16 - SAYI : 4
2005 CİLT : 15 - SAYI : 1
2005 CİLT : 15 - SAYI : 2
2005 CİLT : 15 - SAYI : 3
2005 CİLT : 15 - SAYI : 4
2004 CİLT : 14 - SAYI : 1
2004 CİLT : 14 - SAYI : 2
2004 CİLT : 14 - SAYI : 3
2004 CİLT : 14 - SAYI : 4
2003 CİLT : 13 - SAYI : 1
2003 CİLT : 13 - SAYI : 2
2003 CİLT : 13 - SAYI : 3
2003 CİLT : 13 - SAYI : 4
2002 CİLT : 12 - SAYI : 1
2002 CİLT : 12 - SAYI : 2
2002 CİLT : 12 - SAYI : 3
2002 CİLT : 12 - SAYI : 4
2001 CİLT : 11 - SAYI : 1
2001 CİLT : 11 - SAYI : 2
2001 CİLT : 11 - SAYI : 3
2001 CİLT : 11 - SAYI : 4
2000 CİLT : 10 - SAYI : 1
2000 CİLT : 10 - SAYI : 2
2000 CİLT : 10 - SAYI : 3
2000 CİLT : 10 - SAYI : 4
1999 CİLT : 9 - SAYI : 1
1999 CİLT : 9 - SAYI : 2
1999 CİLT : 9 - SAYI : 3
1999 CİLT : 9 - SAYI : 4
1998 CİLT : 8 - SAYI : 1
1998 CİLT : 8 - SAYI : 2
1998 CİLT : 8 - SAYI : 3
1997 CİLT : 7 - SAYI : 1
1996 CİLT : 6 - SAYI : 1
1995 CİLT : 5 - SAYI : 1
1994 CİLT : 4 - SAYI : 1
1993 CİLT : 3 - SAYI : 1
1992 CİLT : 2 - SAYI : 3
1991 CİLT : 1 - SAYI : 2
1991 CİLT : 1 - SAYI : 3
1991 CİLT : 1 - SAYI : Ek 1
1990 CİLT : 1 - SAYI : 1
Thomas R, Cetin M, Baker GB, Dursun SM.
Comment on FDA’s breakthrough therapy designation of intranasal esketamine for the treatment of major depressive disorder with imminent risk of suicide
Klinik Psikofarmakoloji Bulteni - Bulletin of Clinical Psychopharmacology 2016;26(4):329-31
doi:
10.5455/bcp.20161027122045
Pan E, Ates MA, Algul A, Aytekin A, Basoglu C, Ebrinc S, Cetin M, Kose S.
Fractional anisotropic changes of corpus callosum associated with antipsychotic treatment in first-episode antipsychotic drug-naive patients with schizophrenia
Klinik Psikofarmakoloji Bulteni - Bulletin of Clinical Psychopharmacology 2016;26(4):332-41
doi:
10.5455/bcp.20160319021659
Sirvanci-Yalabik M, Sehirli AO, Utkan T, Aricioglu F.
Agmatine, a metabolite of arginine, improves learning and memory in streptozotocin-induced Alzheimer’s disease model in rats
Klinik Psikofarmakoloji Bulteni - Bulletin of Clinical Psychopharmacology 2016;26(4):342-54
doi:
10.5455/bcp.20161121125642
Nurmedov S, Noyan O, Metin B, Ekmen S, Avcil C, Kose S.
Extensive gray matter volume reduction and correlations with neuropsychological performance in alcohol use disorder patients
Klinik Psikofarmakoloji Bulteni - Bulletin of Clinical Psychopharmacology 2016;26(4):355-63
doi:
10.5455/bcp.20160223123949
Oltulu C, Karadag CH.
The effect of intrauterine antipsychotic drug exposure on learning and memory in adult rats
Klinik Psikofarmakoloji Bulteni - Bulletin of Clinical Psychopharmacology 2016;26(4):364-73
doi:
10.5455/bcp.20160627090254
Yuruyen M, Yavuzer H, Demirdag F, Kara Z, Cengiz M, Yavuzer S, Doventas A, Erdincler DS, Beger T.
Is depression a predictive factor for polypharmacy in elderly?
Klinik Psikofarmakoloji Bulteni - Bulletin of Clinical Psychopharmacology 2016;26(4):374-81
doi:
10.5455/bcp.20160224101558
Boysan M, Kadak MT, Tarakcioglu MC, Sertdurak ZS, Demirel OF.
Psychometric properties of Turkish versions of the Leyton Obsessional Inventory-Child Version (LOI-CV) and Obsessive Beliefs Questionnaire-Child Version (OBQ-CV)
Klinik Psikofarmakoloji Bulteni - Bulletin of Clinical Psychopharmacology 2016;26(4):382-96
doi:
10.5455/bcp.20151203125902
Yavuz F, Ulusoy S, Iskin M, Esen FB, Burhan HS, Karadere ME, Yavuz N.
Turkish version of Acceptance and Action Questionnaire-II (AAQ-II): A reliability and validity analysis in clinical and non-clinical samples
Klinik Psikofarmakoloji Bulteni - Bulletin of Clinical Psychopharmacology 2016;26(4):397-408
doi:
10.5455/bcp.20160223124107
Dalkiran M, Genc A, Dikmen B, Yildirim I, Turan S.
Phantom limb pain treated with duloxetine: a case series
Klinik Psikofarmakoloji Bulteni - Bulletin of Clinical Psychopharmacology 2016;26(4):409-12
doi:
10.5455/bcp.20160411071457
Solomon S, Singaravelu R.
Valproate-induced hyperammonemic encephalopathy in a patient with ischemic stroke
Klinik Psikofarmakoloji Bulteni - Bulletin of Clinical Psychopharmacology 2016;26(4):413-6
doi:
10.5455/bcp.20151209124813
Sahpaz A, Pehlivan S, Turkkan D, Kara DO, Alkurt-Alkan H.
Eosinophilic myocarditis in long term use of antipsychotics: case series and review of the literature
Klinik Psikofarmakoloji Bulteni - Bulletin of Clinical Psychopharmacology 2016;26(4):417-21
doi:
10.5455/bcp.20160502090929
Ertekin H, Ertekin YH, Sahin B, Yayla S, Turkyilmaz E, Kara M.
Clozapine and aripiprazole-induced stuttering: a case report of turner syndrome with schizophrenia
Klinik Psikofarmakoloji Bulteni - Bulletin of Clinical Psychopharmacology 2016;26(4):422-5
doi:
10.5455/bcp.20151204115654
Onen O, Ozek-Erkuran H.
Topiramate in the adjunctıve treatment of tourette syndrome: a case report
Klinik Psikofarmakoloji Bulteni - Bulletin of Clinical Psychopharmacology 2016;26(4):426-8
doi:
10.5455/bcp.20151223092807
Aricioglu F, Sahin-Ozkartal C, Unal G, Dursun S, Cetin M, Müller N.
Neuroinflammation in schizophrenia: a critical review and the future
Klinik Psikofarmakoloji Bulteni - Bulletin of Clinical Psychopharmacology 2016;26(4):429-37
doi:
10.5455/bcp.20161123044657
Camn B.
Restless Leg Syndrome Associated with Aripiprazole
Klinik Psikofarmakoloji Bulteni - Bulletin of Clinical Psychopharmacology 2016;26(4):438-9
doi:
10.5455/bcp.20160411071311
Akcay E, Karadag F, Tunc T.
Psychotic Disorder or Complex Partial Seizure Disorder Due to a Sequelae of Herpes Simplex Encephalitis and Coincidental Parasagittal Meningioma
Klinik Psikofarmakoloji Bulteni - Bulletin of Clinical Psychopharmacology 2016;26(4):439-40
doi:
10.5455/bcp.20160501020819
Uvais N.A.
Autoimmune Psychosis: Caveats in the Diagnosis
Klinik Psikofarmakoloji Bulteni - Bulletin of Clinical Psychopharmacology 2016;26(4):440-2
doi:
10.5455/bcp.20160607074131
Altunsoy N, Enez-Darcin A, Dilbaz N.
Acute Urinary Retention Related with Sublingual Buprenorphine Administration
Klinik Psikofarmakoloji Bulteni - Bulletin of Clinical Psychopharmacology 2016;26(4):442-3
doi:
10.5455/bcp.20150502072514
Sahpolat M, Demir AK.
Risperidone and Lithium for Pathological Laughing
Klinik Psikofarmakoloji Bulteni - Bulletin of Clinical Psychopharmacology 2016;26(4):443-4
doi:
10.5455/bcp.20160316111430